BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/12/2014 8:40:00 PM | Browse: 1234 | Download: 1250
 |
Received |
|
2013-05-19 10:38 |
 |
Peer-Review Started |
|
2013-05-20 12:13 |
 |
To Make the First Decision |
|
2013-07-19 08:28 |
 |
Return for Revision |
|
2013-07-20 20:14 |
 |
Revised |
|
2013-08-04 20:01 |
 |
Second Decision |
|
2013-09-05 11:20 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2013-09-05 12:51 |
 |
Articles in Press |
|
|
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2013-09-26 19:58 |
 |
Publish the Manuscript Online |
|
2013-10-15 17:26 |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Editorial |
Article Title |
Epidermal growth factor receptor and metastatic colorectal cancer: Insights into target therapies
|
Manuscript Source |
Invited Manuscript |
All Author List |
Ramon Andrade de Mello, Andrea Marin Marques and António Araújo |
Funding Agency and Grant Number |
|
Corresponding Author |
Ramon Andrade de Mello, MD, PhD, Department of Medical Oncology, Portuguese Oncology Institute, Rua Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal. ramondemello@gmail.com |
Key Words |
Colorectal cancer; Epidermal growth factor receptor; KRAS mutation; Chemotherapy; Cetuximab; Panitumumab |
Core Tip |
Metastatic colorectal cancer (mCRC) remains a challenge for oncologists worldwide. Despite a very aggressive disease profile, mCRC’s outcomes are improving toward last decades. Target drugs, such as cetuximab and panitumumab, acquired a main role in this scenario whether phase Ⅲ trials showed interesting results in overall survival and disease control. Thus, we will briefly in this paper discuss some issues and pitfalls concerning this framework. |
Publish Date |
2013-10-15 17:26 |
Citation |
de Mello RA, Marques AM, Araújo A. Epidermal growth factor receptor and metastatic colorectal cancer: Insights into target therapies. World J Gastroenterol 2013; 19(38): 6315-6318 |
URL |
http://www.wjgnet.com/1007-9327/full/v19/i38/6315.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v19.i38.6315 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345